ANTX Insider Trading Activity and SEC Form 4 Filings
ANTX insider trading summary
Over the past 12 months, insiders at AN2 Therapeutics, Inc. (ANTX) reported 21 sales worth $406K by 6 insiders and 1 open-market purchase worth $12K by 1 insider on SEC Form 4. Net insider selling was $395K.
Latest ANTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 5, 2026 | Joshua M Eizen | See Remarks | Sell | $12K (2,826 @ $4.22) |
| Sep 9, 2026 | Robin Shane Readnour | Insider | Sell | $3K (523 @ $6.02) |
| Sep 9, 2026 | Robin Shane Readnour | Insider | Sell | $4K (585 @ $6.02) |
| Sep 8, 2026 | Robin Shane Readnour | Insider | Sell | $32K (5,294 @ $6.02) |
| Sep 8, 2026 | Robin Shane Readnour | Insider | Sell | $28K (4,725 @ $6.02) |
| Sep 3, 2026 | Robin Shane Readnour | Insider | Sell | $20K (3,223 @ $6.07) |
| Sep 3, 2026 | Robin Shane Readnour | Insider | Sell | $17K (2,877 @ $6.07) |
| Sep 1, 2026 | Sarah Joanne Williams | Principal Accounting Officer | Sell | $2K (272 @ $5.53) |
| Sep 1, 2026 | Margaret M FitzPatrick | Insider | Buy | $12K (2,098 @ $5.53) |
| Aug 17, 2026 | Robin Shane Readnour | Insider | Sell | $100K (16,696 @ $6.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.